NCT02525562

Stryker NTX Registry Scorpio NRG (Re-"Energize"), Triathlon Total Knee, Triathlon Partial Knee Resurfacing (PKR) With X3 Polyethylene Insert

Stryker NTX Registry Scorpio NRG Triathlon Total Knee, Triathlon PKR With X3 Insert International Multicentre Outcomes Register

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 237 (actual)
• Sponsor: Stryker Orthopaedics · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Provide outcomes information with regard to surgical and implant performance and patient clinical outcomes of the patients who are eligible for either a Total Knee Arthroplasty (TKA) replacement surgery or Partial Knee Resurfacing (unicompartmental knee arthroplasty, UKA)

Detailed description

The objective of this registry is to provide outcomes information with regard to surgical and implant performance and patient clinical outcomes of the patients who are eligible for a either a Total Knee Arthroplasty (TKA) replacement surgery involving the Scorpio NRG or Triathlon Total Knee System or Triathlon PKR Partial Knee Resurfacing (unicompartmental knee arthroplasty, UKA), all of which with X3 inlay. The register will follow the standard clinical procedures used by the institutions for patient selection for knee arthroplasty surgery, patient surgery and patient follow-up. Therefore there will be, with regard to this register, no additional assessment, examination, procedure or follow-up visits compared to those usually performed in the institution (routine standard normal procedures).

Conditions

• Arthroplasty, Replacement, Knee

Interventions

Type	Name	Description
DEVICE	Triathlon Total Knee System with X3 insert	Total knee replacement
DEVICE	Scorpio NRG Total Knee System with X3 insert	Total knee replacement
DEVICE	Triathlon PKR System with X3 insert	Partial Knee Resurfacing
PROCEDURE	Total Knee Replacement	Total Knee Replacement
PROCEDURE	Partial Knee Resurfacing	Partial Knee Resurfacing

Timeline

• Start date: 2012-06-28
• Primary completion: 2020-05-28
• Completion: 2020-05-28
• First posted: 2015-08-17
• Last updated: 2024-02-22
• Results posted: 2023-03-14

Locations

3 sites across 3 countries: Germany, Luxembourg, United Kingdom

Regulatory

• FDA-regulated device study